BioLineRx Ltd. (BLRX)
NASDAQ: BLRX
· Real-Time Price · USD
3.83
0.12 (3.23%)
At close: Aug 18, 2025, 3:57 PM
3.83
0.13%
After-hours: Aug 18, 2025, 04:10 PM EDT
BioLineRx Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 5.13M | -3.19M | -5.82M | 484K | -696K | -13.88M | -16.02M | -18.55M | -12.16M | -5.73M | -6.85M | -7.44M | -4.93M | -4.3M | -5.72M | -6.84M | -10.19M |
Depreciation & Amortization | 165K | 1.85M | 840K | 476K | 897K | 706K | 221K | 198K | 259K | 187K | 153K | 141K | 173K | 174K | 167K | 180K | 182K |
Stock-Based Compensation | 194K | -154K | 319K | 437K | 533K | 929K | 472K | 485K | 435K | 1.04M | 614K | 330K | 256K | 391K | 272K | 361K | 471K |
Other Working Capital | -1.35M | -1.94M | -3.09M | -6.11M | -7.36M | 15.31M | 2.52M | -948K | 273K | 1.26M | -1.01M | 816K | n/a | 372K | 1.04M | n/a | n/a |
Other Non-Cash Items | -7.56M | -6.71M | -1.73M | -5.52M | -4.07M | -1.14M | 1.11M | 1.15M | 3.18M | -2.45M | -1.59M | -133K | -1.26M | -21K | -13K | 18K | 55K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 3.68M | 3.15M | 7.97M | n/a | n/a | n/a | n/a | n/a | -2.34M | -767K | 158K | 4.73M |
Change in Working Capital | -513K | -410K | -3.43M | -7.2M | -10.77M | 14.71M | 1.17M | -948K | 273K | 1.26M | -1.01M | 816K | 172K | 597K | 1.04M | -703K | -1.48M |
Operating Cash Flow | -2.59M | -8.61M | -9.82M | -11.33M | -14.11M | 4.99M | -9.9M | -9.68M | -8.02M | -5.68M | -8.68M | -6.29M | -5.59M | -5.5M | -5.01M | -6.83M | -6.23M |
Capital Expenditures | n/a | 6K | n/a | -27K | -32K | -18K | -27K | -123K | -129K | -228K | -26K | -44K | -18K | -62K | 3K | -19K | -19K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 2K | 26K | 56K | -6.67K | -3.92K | 14.92K | -10.07K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -12.31M | n/a | -5.79M | -20.56M | n/a | -33.71M | -7.88M | -506K | -5.5M | -8M | -27M | -2M | -7M | -8M | -12M | -16M | -42M |
Sales Maturities Of Investments | 4.13M | 11.15M | 15.97M | 11.94M | 16.72M | 13.33M | 12M | 11.73M | 12.27M | 12.09M | 12.09M | 12.07M | 12.07M | 12.06M | 12.04M | 10.02M | 5.76M |
Other Investing Acitivies | n/a | -1K | n/a | n/a | n/a | -2K | -26K | -56K | 6.67K | 3.92K | -14.92K | 10.07K | n/a | n/a | -35K | n/a | n/a |
Investing Cash Flow | -8.18M | 11.16M | 10.18M | -8.64M | 16.69M | -20.39M | 4.1M | 11.1M | 6.64M | 3.86M | -14.94M | 10.03M | 5.05M | 4M | 40K | -6M | -36.26M |
Debt Repayment | -1.25M | -12.1M | -1.04M | -909K | -894K | -863K | -942K | -134K | -49K | -94K | 8.62M | -957K | -943K | -925K | -877K | -907K | -863K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -5K | 27K | 24.79M | n/a | 410K | 2.54M | n/a | n/a | -553K | n/a | 2K | n/a | n/a | n/a | 10.91M | 5K |
Financial Cash Flow | 9.45M | -1.11M | -1.22M | 23.88M | -894K | 11.74M | 3.5M | -134K | -49K | -647K | 22.72M | -689K | -943K | 174K | 1.57M | 14.09M | 41.91M |
Net Cash Flow | -1.4M | 1.6M | -787K | 3.63M | 1.74M | -3.47M | -2.38M | 1.04M | -1.52M | -2.52M | -895K | 2.55M | -1.54M | -1.09M | -3.41M | 1.44M | -784K |
Free Cash Flow | -2.59M | -8.61M | -9.82M | -11.36M | -14.14M | 4.97M | -9.93M | -9.8M | -8.14M | -5.91M | -8.71M | -6.33M | -5.6M | -5.57M | -5.01M | -6.85M | -6.25M |